Company / Current Liabilities
Praxis Precision Medicines, Inc. Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$59.8M
FY2025
5-year range
$15.7M / $59.8M
FY2021-FY2025
Trend
+59.2%
vs FY2024
Sector context
#131 of 213
Health Care
What the data says
At $60M, Praxis Precision Medicines, Inc.'s current liabilities ranks #83 of 213 in the Health Care sector. Increased from $16M to $60M over the past 2 years.
Based on SEC 10-K filings.
$60M in FY2025 with a 5-year CAGR of +30.6%.
Increased from $16M to $60M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +20.3%
- 5-Year CAGR
- +30.6%
- 10-Year CAGR
- -
Sector benchmark
#83 of 213 in Health CareTop 38% of 213This company $59.8M Sector average $1.6B
▼
-96.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +30.6%, indicating consistent growth.
- In FY2025, current liabilities increased 59.2% year-over-year.
- Ranks #131 out of 213 companies in the Health Care sector.
- Lowest current liabilities in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $59.8M | +59.2% |
| FY2024 | $37.5M | +138.4% |
| FY2023 | $15.7M | -54.1% |
| FY2022 | $34.3M | -10.6% |
| FY2021 | $38.4M | +144.5% |
| FY2020 | $15.7M | +130.6% |
| FY2019 | $6.8M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026